Fumoto, S.; Tanimoto, K.; Noguchi, T.; Hihara, J.; Hiyama, E.; Otani, K.; Ohtaki, M.; Shimada, Y.; Nishiyama, M.; Hiyama, K.
Unique Function in Cancer Stemness and Prognostic Significance of EMX2 in Esophageal Squamous Cell Carcinoma. Biomedicines 2025, 13, 1373.
https://doi.org/10.3390/biomedicines13061373
AMA Style
Fumoto S, Tanimoto K, Noguchi T, Hihara J, Hiyama E, Otani K, Ohtaki M, Shimada Y, Nishiyama M, Hiyama K.
Unique Function in Cancer Stemness and Prognostic Significance of EMX2 in Esophageal Squamous Cell Carcinoma. Biomedicines. 2025; 13(6):1373.
https://doi.org/10.3390/biomedicines13061373
Chicago/Turabian Style
Fumoto, Shoichi, Keiji Tanimoto, Takuya Noguchi, Jun Hihara, Eiso Hiyama, Keiko Otani, Megu Ohtaki, Yutaka Shimada, Masahiko Nishiyama, and Keiko Hiyama.
2025. "Unique Function in Cancer Stemness and Prognostic Significance of EMX2 in Esophageal Squamous Cell Carcinoma" Biomedicines 13, no. 6: 1373.
https://doi.org/10.3390/biomedicines13061373
APA Style
Fumoto, S., Tanimoto, K., Noguchi, T., Hihara, J., Hiyama, E., Otani, K., Ohtaki, M., Shimada, Y., Nishiyama, M., & Hiyama, K.
(2025). Unique Function in Cancer Stemness and Prognostic Significance of EMX2 in Esophageal Squamous Cell Carcinoma. Biomedicines, 13(6), 1373.
https://doi.org/10.3390/biomedicines13061373